Patents by Inventor Giulio Jori

Giulio Jori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20010051760
    Abstract: The invention relates to the use of photofrin as a radiosensitizer in the treatment of tumorous tissue, wherein after a predetermined time interval after application of the photofrin an irradiation of the tumorous tissue with ionizing radiation is effected.
    Type: Application
    Filed: April 27, 2001
    Publication date: December 13, 2001
    Inventors: Alfons Hofstetter, Eckhart Duhmke, Moshe Schaffer, Giulio Jori, Luigi Corti
  • Patent number: 6225333
    Abstract: The present invention in general terms includes a method of treating cancerous cells containing a pigment, the method including irradiation of the cells with light of comprising the steps: (1) subjecting the cancerous cells to relatively high power light so as to substantially reduce the amount of the pigment in the cells; (2) treating the cancerous cells with one or more photosensitizing agent; followed by (3) subjecting the cancerous cells to relatively low power light so as to activate the photosensitizing agent(s).
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: May 1, 2001
    Assignee: Bowling Green State University
    Inventors: Michael A. J. Rodgers, Giulio Jori, Malcolm E. Kenney
  • Patent number: 6107326
    Abstract: Cationic porphycenes are conjugated, through a carboxylic-acid bearing moiety, with polylysine through an amide linkage. The novel porphycenes are effective in treating microbial populations in vitro or in vivo and topically as well as for sterilizing articles.
    Type: Grant
    Filed: April 12, 1999
    Date of Patent: August 22, 2000
    Assignee: Cytopharm, Inc.
    Inventor: Giulio Jori
  • Patent number: 6071944
    Abstract: The present invention in general terms includes a method of treating cancerous cells containing a pigment, the method including irradiation of the cells with light of comprising the steps: (1) subjecting the cancerous cells to relatively high power light so as to substantially reduce the amount of the pigment in the cells; (2) treating the cancerous cells with one or more photosensitizing agent; followed by (3) subjecting the cancerous cells to relatively low power light so as to activate the photosensitizing agent(s).
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: June 6, 2000
    Assignee: Bowling Green State University
    Inventors: Michael A. J. Rodgers, Giulio Jori, Malcolm E. Kenney
  • Patent number: 5965598
    Abstract: The present invention refers to zinc-phthalocyanines of general formula (I) ##STR1## to processes for their preparation and to their use as phototherapeutic and photodiagnostic agents as free molecules and as conjugates with macromolecular carrier molecules.
    Type: Grant
    Filed: August 13, 1998
    Date of Patent: October 12, 1999
    Assignee: Molteni L. & C. dei Fratelli Alitti Societa di esercizio S.p.A.
    Inventors: Gabrio Roncucci, Donata Dei, Maria Paola De Filippis, Lia Fantetti, Ilaria Masini, Barbara Cosimelli, Giulio Jori
  • Patent number: 5286474
    Abstract: A process of tumor identification comprising administering a carotenoporphyrin to a tumor-bearing mammalian host and irradiating the mammalian host with light whereupon the carotenoporphyrin, which has been preferentially taken up by the tumor tissue, fluoresces and permits precise identification of the location, size and shape of the tumor tissue. An improved process of synthesizing carotenoporphyrins 1-5 is also provided.
    Type: Grant
    Filed: October 22, 1992
    Date of Patent: February 15, 1994
    Assignee: Arizona Board of Regents, a body corporate, acting for and on behalf the Arizona State University
    Inventors: John D. Gust, Jr., Ana L. Moore, Thomas A. Moore, Giulio Jori, Elena Reddi
  • Patent number: 5015478
    Abstract: The therapeutic compositions of this invention comprise one or more porphycene compounds incorporated within liposomes. The method of this invention for treating cancer comprises administering a therapeutically effective amount of a porphycene derivative to a patient, and exposing an affected body area of the patient to a therapeutically sufficient amount of light having a wavelength of from 600 to 950 nm.
    Type: Grant
    Filed: November 22, 1989
    Date of Patent: May 14, 1991
    Assignee: Cytopharm, Inc.
    Inventors: Giulio Jori, Matthias Kocher, Emanuel Vogel, Alexander D. Cross
  • Patent number: 4913907
    Abstract: The therapeutic compositions of this invention comprise one or more porphycene compounds incorporated within liposomes. The method of this invention for treating cancer comprises administering a therapeutically effective amount of a porphycene derivative to a patient, and exposing an affected body area of the patient to a therapeutically sufficient amount of light having a wavelength of from 600 to 950 nm.
    Type: Grant
    Filed: August 15, 1988
    Date of Patent: April 3, 1990
    Assignee: Cytopharm, Inc.
    Inventors: Giulio Jori, Matthias Kocher, Emanuel Vogel, Alexander D. Cross